US Seeks $1B From J&J Over Risperdal Marketing
Prosecutors reportedly were seeking about $1 billion from Johnson & Johnson on Thursday to settle a federal criminal investigation into the company's off-label promotion of the antipsychotic drug Risperdal....To view the full article, register now.
Already a subscriber? Click here to view full article